🇺🇸 FDA
Patent

US 11932695

Modified antibodies and related compounds, compositions and methods of use

granted A61KA61K47/54A61K47/545

Quick answer

US patent 11932695 (Modified antibodies and related compounds, compositions and methods of use) held by Sensei Biotherapeutics, Inc. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sensei Biotherapeutics, Inc.
Grant date
Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K47/54, A61K47/545, A61P, A61P35/00